SCHEDULE 13D

Company

MOLECULAR PARTNERS AG

Filed

November 20, 2023

Accession Number

0000921895-23-002672

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →